- Open Access
Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
Journal for ImmunoTherapy of Cancer volume 7, Article number: 349 (2019)
Correction to: J ImmunoTher Cancer (2019) 7:288
Following publication of the original article , the authors have reported that Fig. 2 and Additional file 1: Figure S1, S2 partially show red scripts.
In Fig. 2:
A: Red font “MHC-I (MFI x 103)” should change to black font;
C: Red font “0.07” and “M-MDSC” should change to black font.
In Additional file 1: Figure S1, S2:
S1: Red font “Spleen” and “Tumor” should change to black font;
S2: Red font “C”, “D”, “E”, “F”, “G”, “H” should change to black font.
The correct version of the figures can be found below.
The corrections have been implemented in the original article as well.
We apologize for the inconvenience.
Metzger, et al. J ImmunoTher Cancer. 2019;7:288. https://doi.org/10.1186/s40425-019-0778-7.
The original version of this article was revised: the authors have reported that Figure 2 and S2 partially show red scripts.
Additional file 1: Figure S1.
. Gating strategy for the identification of MDSC populations. Figure S2. Poly(I:C)c reduces macrophage frequency and activates macrophages, cDC, B and NK cells. Figure S3. Poly(I:C)c triggers transcriptional reprogramming of MDSC. Figure S4. Significantly regulated genes in PMN- and M-MDSC upon poly(I:C)c therapy.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Metzger, P., Kirchleitner, S.V., Kluge, M. et al. Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. j. immunotherapy cancer 7, 349 (2019). https://doi.org/10.1186/s40425-019-0830-7